FI961506A0 - Distamysiini A -analogit antituumorisina ja antiviraalisina aineina - Google Patents
Distamysiini A -analogit antituumorisina ja antiviraalisina aineinaInfo
- Publication number
- FI961506A0 FI961506A0 FI961506A FI961506A FI961506A0 FI 961506 A0 FI961506 A0 FI 961506A0 FI 961506 A FI961506 A FI 961506A FI 961506 A FI961506 A FI 961506A FI 961506 A0 FI961506 A0 FI 961506A0
- Authority
- FI
- Finland
- Prior art keywords
- antitumor
- antiviral agents
- pct
- distamycin
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9416005A GB9416005D0 (en) | 1994-08-08 | 1994-08-08 | Peptidic compounds analogous to distamycin a and process for their preparation |
PCT/EP1995/002814 WO1996005196A1 (en) | 1994-08-08 | 1995-07-18 | Distamycin a analogues as antitumour or antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
FI961506A0 true FI961506A0 (fi) | 1996-04-03 |
FI961506A FI961506A (fi) | 1996-06-05 |
Family
ID=10759569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961506A FI961506A (fi) | 1994-08-08 | 1996-04-03 | Distamysiini A -analogit antituumorisina ja antiviraalisina aineina |
Country Status (19)
Country | Link |
---|---|
US (1) | US5753629A (fi) |
EP (1) | EP0722446B1 (fi) |
JP (1) | JPH09504039A (fi) |
KR (1) | KR960704884A (fi) |
CN (1) | CN1131946A (fi) |
AT (1) | ATE229524T1 (fi) |
AU (1) | AU689623B2 (fi) |
CA (1) | CA2172629A1 (fi) |
DE (1) | DE69529143T2 (fi) |
ES (1) | ES2188666T3 (fi) |
FI (1) | FI961506A (fi) |
GB (1) | GB9416005D0 (fi) |
HU (1) | HUT76267A (fi) |
IL (1) | IL114794A0 (fi) |
NO (1) | NO961377L (fi) |
NZ (1) | NZ290404A (fi) |
PL (1) | PL313821A1 (fi) |
WO (1) | WO1996005196A1 (fi) |
ZA (1) | ZA956590B (fi) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635417B1 (en) | 1996-07-31 | 2003-10-21 | California Institute Of Technology | Complex formation between DSDNA and oligomer of cyclic heterocycles |
US6143901A (en) * | 1996-07-31 | 2000-11-07 | Genesoft, Inc. | Complex formation between dsDNA and pyrrole imidazole polyamides |
US6090947A (en) | 1996-02-26 | 2000-07-18 | California Institute Of Technology | Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
EP1023288A1 (en) | 1996-02-26 | 2000-08-02 | California Institute Of Technology | Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove |
CN1260006A (zh) * | 1996-02-26 | 2000-07-12 | 加利福尼亚州技术学院 | 双链dna和杂环低聚物之间复合物的形成 |
AU6255298A (en) | 1996-02-26 | 1998-09-09 | California Institute Of Technology | Design, synthesis and use of specific polyamide dna-binding ligands |
WO1998037066A1 (en) * | 1996-02-26 | 1998-08-27 | California Institute Of Technology | Improved polyamides for binding in the minor groove of double stranded dna |
US6555692B1 (en) | 1996-02-26 | 2003-04-29 | California Institute Of Technology | Preparation and use of bifunctional molecules having DNA sequence binding specificity |
US6506906B1 (en) | 1996-02-26 | 2003-01-14 | California Institute Of Technology | Preparation and use of bifunctional molecules having DNA sequence binding specificity |
GB9610079D0 (en) * | 1996-05-14 | 1996-07-17 | Pharmacia Spa | Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents |
US5998140A (en) * | 1996-07-31 | 1999-12-07 | The Scripps Research Institute | Complex formation between dsDNA and oligomer of cyclic heterocycles |
GB9623522D0 (en) * | 1996-11-11 | 1997-01-08 | Pharmacia & Upjohn Spa | Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents |
GB9806692D0 (en) * | 1998-03-27 | 1998-05-27 | Pharmacia & Upjohn Spa | Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents |
GB9806689D0 (en) | 1998-03-27 | 1998-05-27 | Pharmacia & Upjohn Spa | Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents |
US6384005B1 (en) * | 1998-04-27 | 2002-05-07 | Procter & Gamble Company | Garment conditioning composition |
GB9812211D0 (en) * | 1998-06-05 | 1998-08-05 | Pharmacia & Upjohn Spa | Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents |
GB9928703D0 (en) * | 1999-12-03 | 2000-02-02 | Pharmacia & Upjohn Spa | Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents |
US6555693B2 (en) | 2000-03-16 | 2003-04-29 | Genesoft, Inc. | Charged compounds comprising a nucleic acid binding moiety and uses therefor |
US7078536B2 (en) * | 2001-03-14 | 2006-07-18 | Genesoft Pharmaceuticals, Inc. | Charged compounds comprising a nucleic acid binding moiety and uses therefor |
GB0011059D0 (en) * | 2000-05-08 | 2000-06-28 | Pharmacia & Upjohn Spa | Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione |
GB0015447D0 (en) | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents |
GB0015446D0 (en) | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites |
GB0016447D0 (en) | 2000-07-04 | 2000-08-23 | Pharmacia & Upjohn Spa | Process for preparing distamycin derivatives |
GB0029004D0 (en) | 2000-11-28 | 2001-01-10 | Pharmacia & Upjohn Spa | Process for preparing distamycin derivatives |
WO2002088119A1 (en) * | 2001-04-26 | 2002-11-07 | Genesoft Pharmaceuticals, Inc | Halogen-substituted thienyl compounds |
CA2450628A1 (en) * | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Benzothiophene compounds having antiinfective activity |
WO2002101007A2 (en) * | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc | Antipathogenic benzamide compounds |
ITTO20010633A1 (it) | 2001-07-02 | 2003-01-02 | Univ Ferrara | Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a. |
US6969592B2 (en) | 2001-09-26 | 2005-11-29 | Pharmacia Italia S.P.A. | Method for predicting the sensitivity to chemotherapy |
GB0130868D0 (en) * | 2001-12-24 | 2002-02-06 | Univ Strathclyde | New compounds |
ATE425753T1 (de) | 2002-08-02 | 2009-04-15 | Genesoft Pharmaceuticals Inc | Biaryl-verbindungen mit antiinfektiver wirkung |
CA2503119A1 (en) * | 2002-10-25 | 2004-05-13 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
US7129214B2 (en) | 2002-12-10 | 2006-10-31 | Oscient Pharmaceuticals Corporation | Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
JP2006525361A (ja) * | 2003-05-02 | 2006-11-09 | エラン ファーマシューティカルズ,インコーポレイテッド | ブラジキニンb1受容体アンタゴニストとしての選択された置換ピラゾール誘導体および関連化合物 |
US20050038099A1 (en) * | 2003-05-02 | 2005-02-17 | Tung Jay S. | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
US7417152B2 (en) * | 2003-05-02 | 2008-08-26 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases |
GB0619325D0 (en) * | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
CN104845967B (zh) | 2015-04-15 | 2020-12-11 | 苏州新海生物科技股份有限公司 | 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用 |
WO2018047148A1 (en) | 2016-09-12 | 2018-03-15 | Novartis Ag | Compounds for the inhibition of mirna |
EP3381897A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE468642B (sv) * | 1985-07-16 | 1993-02-22 | Erba Farmitalia | Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition |
GB8612218D0 (en) * | 1986-05-20 | 1986-06-25 | Erba Farmitalia | Site specific alkylating agents |
GB8906709D0 (en) * | 1989-03-23 | 1989-05-10 | Creighton Andrew M | Acryloyl substituted pyrrole derivatives |
IT1271456B (it) * | 1993-03-01 | 1997-05-28 | Menarini Farma Ind | Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono |
IT1263089B (it) * | 1993-04-26 | 1996-07-24 | Menarini Farma Ind | Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono. |
-
1994
- 1994-08-08 GB GB9416005A patent/GB9416005D0/en active Pending
-
1995
- 1995-07-18 NZ NZ290404A patent/NZ290404A/en unknown
- 1995-07-18 DE DE69529143T patent/DE69529143T2/de not_active Expired - Fee Related
- 1995-07-18 AT AT95926927T patent/ATE229524T1/de not_active IP Right Cessation
- 1995-07-18 JP JP8506945A patent/JPH09504039A/ja active Pending
- 1995-07-18 CN CN95190742A patent/CN1131946A/zh active Pending
- 1995-07-18 CA CA002172629A patent/CA2172629A1/en not_active Abandoned
- 1995-07-18 AU AU31136/95A patent/AU689623B2/en not_active Ceased
- 1995-07-18 HU HU9601218A patent/HUT76267A/hu unknown
- 1995-07-18 WO PCT/EP1995/002814 patent/WO1996005196A1/en active IP Right Grant
- 1995-07-18 KR KR1019960701819A patent/KR960704884A/ko not_active Application Discontinuation
- 1995-07-18 PL PL95313821A patent/PL313821A1/xx unknown
- 1995-07-18 US US08/612,836 patent/US5753629A/en not_active Expired - Fee Related
- 1995-07-18 EP EP95926927A patent/EP0722446B1/en not_active Expired - Lifetime
- 1995-07-18 ES ES95926927T patent/ES2188666T3/es not_active Expired - Lifetime
- 1995-08-01 IL IL11479495A patent/IL114794A0/xx unknown
- 1995-08-07 ZA ZA956590A patent/ZA956590B/xx unknown
-
1996
- 1996-04-03 FI FI961506A patent/FI961506A/fi unknown
- 1996-04-03 NO NO961377A patent/NO961377L/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL114794A0 (en) | 1995-12-08 |
DE69529143D1 (en) | 2003-01-23 |
AU3113695A (en) | 1996-03-07 |
NO961377D0 (no) | 1996-04-03 |
AU689623B2 (en) | 1998-04-02 |
US5753629A (en) | 1998-05-19 |
ZA956590B (en) | 1996-03-18 |
ES2188666T3 (es) | 2003-07-01 |
NZ290404A (en) | 1997-04-24 |
ATE229524T1 (de) | 2002-12-15 |
KR960704884A (ko) | 1996-10-09 |
DE69529143T2 (de) | 2003-09-11 |
NO961377L (no) | 1996-05-30 |
GB9416005D0 (en) | 1994-09-28 |
PL313821A1 (en) | 1996-07-22 |
MX9601250A (es) | 1998-12-31 |
FI961506A (fi) | 1996-06-05 |
EP0722446B1 (en) | 2002-12-11 |
CN1131946A (zh) | 1996-09-25 |
CA2172629A1 (en) | 1996-02-22 |
WO1996005196A1 (en) | 1996-02-22 |
HU9601218D0 (en) | 1996-07-29 |
EP0722446A1 (en) | 1996-07-24 |
HUT76267A (en) | 1997-07-28 |
JPH09504039A (ja) | 1997-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961506A0 (fi) | Distamysiini A -analogit antituumorisina ja antiviraalisina aineina | |
ES2152414T3 (es) | Dihidrobenzofuranos. | |
ATE191334T1 (de) | Hydrophilierte zahnabdruckmassen | |
FI932229A (fi) | Azabicykliska bryggderivat | |
AU697150B2 (en) | Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation | |
DE69811062D1 (de) | Polyaromatische antivirale zusammensetzungen | |
ATE206402T1 (de) | 3-acylaminobenzazepine | |
BR9509970A (pt) | Composto | |
FI970449A (fi) | N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina | |
DK0623620T3 (da) | 5-HT3-pyrrolopyrazinderivater | |
SE9402241L (sv) | Inhibitor | |
FI963166A (fi) | Uusia merkaptoasetyyliamididisulfidijohdannaisia, jotka ovat käyttökelpoisia enkefalinaasin ja ACE:n inhibiittoreina | |
DK0544171T3 (da) | Anvendelse af 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11-oximer til fremstilling af antiretrovirale midler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: PHARMACIA & UPJOHN S.P.A. |